mesalamine has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delgado, J | 1 |
| Delgado, B | 1 |
| Sztarkier, I | 1 |
| Cagnano, E | 1 |
| Sperber, AD | 1 |
| Fich, A | 1 |
1 other study available for mesalamine and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Granulomatous Disease, Chronic; Huma | 2003 |